TB-LAM in the Diagnosis of TB
Clinical Utility of TB-LAM in the Diagnosis of Active TB in Hospitalized HIV-infected Patients
Sponsor: Shanghai Public Health Clinical Center
Listed as NCT04600232, this NA trial focuses on HIV Infections and Non-Tuberculous Mycobacterial Pneumonia and remains ongoing. Sponsored by Shanghai Public Health Clinical Center, it has been updated 5 times since 2020, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.
Status Flow
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Unknown NA
-
Jul 2024 — Sep 2024 [monthly]
Unknown NA
Status: Unknown Status → Unknown
-
Nov 2022 — Jul 2024 [monthly]
Unknown Status NA
Status: Not Yet Recruiting → Unknown Status
-
Jan 2021 — Nov 2022 [monthly]
Not Yet Recruiting NA
-
Nov 2020 — Jan 2021 [monthly]
Not Yet Recruiting NA
First recorded
Oct 2020
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Shanghai Public Health Clinical Center
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.